Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

Background: Real world evidence data regarding secukinumab (SEC) use in biologic-experienced patients with psoriatic arthritis (PsA) are scarce.Objectives: To assess the real life survival, safety and efficacy of SEC in biologic-experienced patients with PsA.Methods: All biologic-experienced PsA pat...

Full description

Bibliographic Details
Main Authors: Kalliopi Klavdianou, Argyro Lazarini, Alexandros Grivas, Dimitrios Tseronis, Christina Tsalapaki, Panagiota Rapsomaniki, Katerina Antonatou, Konstantinos Thomas, Dimitrios Boumpas, Pelagia Katsimbri, Dimitrios Vassilopoulos
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Medicine
Subjects:
psoriatic arthritis
secukinumab
tumor necrosis factor inhibitors
biologic agents
real world evidence
ustekinumab
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00288/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00288/full

Similar Items